Completing data — refresh the page later to see the latest
286367-79-1[2H]c1nc([2H])c([2H])c(N([2H])[2H])c1[2H]NUKYPUAOHBNCPY-UDDMDDBKSA-N286367-79-1、45498-20-2Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]
Acute Tox. 2 (100%)
Acute Tox. 2 (100%)
UsesDalfampridine D6 is used in characterizing subtypes of potassium channel, and has also been used to manage some of the symptoms of multiple sclerosis, and is indicated f or symptomatic improvement of walking in adults with several variations of the disease. Dalfampridine is a precursor to the drug Pinacidil.